Concepedia

Author

Sylvia Zapf

Boehringer Ingelheim (Germany)

Also Known As

S Zapf, S. ZAPF, SYLVIA ZAPF, Sylvia Zapf

8

Publications

177

Citations

6

H-Index

10

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Lund UniversityInstitute of Organic Chemistry
SZ

About

Sylvia Zapf is an author at Boehringer Ingelheim (Germany) specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

59

2

Natural Sciences

2

2

22

3

Biochemistry

2

2

22

4

Pharmacology

2

2

22

5

Microbiology

1

1

37

Sylvia Zapf

×

5

Publications

159

Citations

5

H-Index

YearCitations

Darlucins A and B, New Isocyanide Antibiotics from Sphaerellopsis filum(Darluca filum).

Sylvia Zapf, MARTIN HOßFELD, Heidrun Anke,

The Journal of Antibiotics

1995

78

Incrustoporin, a New Antibiotic from Incrustoporia carneola (Bres.) Ryv. (Basidiomycetes).

Sylvia Zapf, Timm Anke, Olov Sterner,

Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry

1995

37

Favolon, a New Antifungal Triterpenoid from a Favolaschia Species.

Timm Anke, Andreas Werle, Sylvia Zapf,

The Journal of Antibiotics

1995

22

(+)-10α-Hydroxy-4-muurolen-3-one, a New Inhibitor of Leukotriene Biosynthesis from a Favolaschia Species. Comparison with Other Sesquiterpenes

Sylvia Zapf, Annette Wunder, Timm Anke,

Zeitschrift für Naturforschung C

1996

12

(+)-10 alpha-Hydroxy-4-muurolen-3-one, a new inhibitor of leukotriene biosynthesis from a Favolaschia species. Comparison with other sesquiterpenes.

Sylvia Zapf, Annette Wunder, Timm Anke,

PubMed

1997

10

Page 1